| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1d39d236f73130a96887af1e7f1c455 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01F17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01F17-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01F17-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01F17-10 |
| filingDate |
2021-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba5dfb76da705fa059d1f6e8faa4fdb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64667f11b9541c20c9f9dfc6e85e2a3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f942c9d2f2d2e3694ca9dd7ad712b56 |
| publicationDate |
2021-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113116924-A |
| titleOfInvention |
Application of cerium oxide nanoparticles in the preparation of drugs for enhancing the activity of cytotoxic CD8+ T cells |
| abstract |
The invention relates to the application of a cerium oxide nanoparticle in the preparation of a drug for enhancing the activity of cytotoxic CD8+ T cells, belonging to the technical field of biomedicine. The secretion of factors and the synthesis of effector molecules enhanced the specific antigen killing ability of cytotoxic CD8 + T cells, and it was found in animal experiments that cerium oxide nanoparticles enhanced the body's ability to clear viruses. The new application of cerium oxide nanoparticles provides a new idea for the clinical treatment of diseases with cytotoxic CD8+ T cells as the therapeutic target. |
| priorityDate |
2021-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |